September 25, 2026

Drax targets a bigger role as Britain reshapes its power system

Britain needs more than renewable generation to reshape its power system, and Drax is developing generation, storage and flexibility assets to address that need...

Valeura Energy features in 2026 TSX 30 as energy and commodities drive market interest

Valeura Energy’s inclusion in the 2026 TSX 30 highlights its position within a market increasingly focused on energy security, commodity supply and international production...

Peptide drug development expands beyond GLP-1

GLP-1 success is widening interest in peptide drug development, with the next phase focused on proving clinical value across new therapeutic areas...

AngioDynamics, Inc. (ANGO) Investor Outlook: Unpacking the 30.89% Potential Upside

For investors keen on exploring opportunities within the healthcare sector, AngioDynamics, Inc. (NASDAQ: ANGO) presents a compelling case with a notable potential upside of 30.89%. This medical technology company, headquartered..

Kamada Ltd. (KMDA) Stock Analysis: Exploring 52.89% Potential Upside Amid Robust Revenue Growth

Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector specializing in plasma-derived protein therapeutics, has been making waves with its impressive financial metrics and growth prospects. Headquartered in..

Oruka Therapeutics, Inc. (ORKA): Analyst Consensus Highlights 81% Potential Upside

Oruka Therapeutics, Inc. (ORKA), a clinical-stage biopharmaceutical company based in Menlo Park, California, is garnering significant attention from investors focused on high-growth opportunities in the biotechnology sector. With a market..

Septerna, Inc. (SEPN) Stock Analysis: Unveiling a 42% Potential Upside Amidst Biotech Innovation

Investors are increasingly turning their attention to Septerna, Inc. (NASDAQ: SEPN), a burgeoning player in the biotechnology sector, driven by its promising potential upside and cutting-edge developments in the field..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Unpacking a Promising 113.73% Potential Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) stands out in the biotechnology sector with a market capitalization of approximately $993.64 million. This clinical-stage biopharmaceutical company, headquartered in Cambridge, Massachusetts, focuses on developing..

Standard BioTools Inc. (LAB) Stock Analysis: Exploring an 81.7% Potential Upside in the Medical Devices Sector

Standard BioTools Inc. (NASDAQ: LAB) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $291.69 million, this Boston-based company is capturing..

Touchstone Exploration moves ahead with Trinidad drilling and production plans

Touchstone Exploration is advancing drilling, well work and production optimisation across Trinidad, with several key operational results expected during the rest of 2026...

Sonida Senior Living, Inc. (SNDA): Investor Outlook Reveals 31.82% Potential Upside in Healthcare Sector

Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector specializing in senior housing communities, presents a compelling opportunity for investors seeking growth in the medical care facilities..

Celcuity Inc. (CELC) Stock Analysis: Exploring a Promising 102% Potential Upside in Biotechnology

For investors with a keen interest in the biotechnology sector, Celcuity Inc. (NASDAQ: CELC) presents a compelling opportunity. This clinical-stage biotech firm, headquartered in Minneapolis, is at the forefront of..

Personalis, Inc. (PSNL) Stock Analysis: Navigating Growth with Strategic Collaborations in the Healthcare Sector

Personalis, Inc. (NASDAQ: PSNL), a key player in the healthcare sector’s diagnostics and research industry, has been making waves with its innovative approach to cancer genomic testing. Headquartered in Fremont,..

MBX Biosciences, Inc. (MBX)

⚠️ No article content returned.

..

Precigen, Inc. (PGEN) Stock Analysis: Unveiling a Potential 87.99% Upside for Biotech Investors

Precigen, Inc. (PGEN), a trailblazing biopharmaceutical entity headquartered in Germantown, Maryland, is capturing investor attention with its ambitious focus on gene and cell therapies targeted at immuno-oncology, autoimmune disorders, and..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a 20% Potential Upside in the Pediatric Orthopedic Market

OrthoPediatrics Corp. (NASDAQ: KIDS) stands as a prominent player in the healthcare sector, particularly within the specialized niche of medical devices for pediatric orthopedic conditions. With a market capitalization of..

Claritev Corporation (CTEV) Stock Analysis: Healthcare Data Leader Eyes 96% Potential Upside

Claritev Corporation (NASDAQ: CTEV), a prominent player in the healthcare sector, specializes in data analytics and technology-enabled cost management solutions. With a market capitalization of $395.89 million, this health information..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 217.68% Potential Upside in the Biotech Sector

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a burgeoning player in the biotechnology realm, is capturing the attention of investors with its notable potential upside of 217.68%. Headquartered in Watertown, Massachusetts, Tectonic..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Navigating a Stable Path with Strategic Collaborations

Theravance Biopharma, Inc. (NASDAQ: TBPH), a key player in the biotechnology sector, continues to attract attention from investors due to its strategic collaborations and innovative product pipeline. As of now,..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Promising 85.88% Potential Upside Ignites Investor Interest

Rapport Therapeutics, Inc. (NASDAQ: RAPP), a burgeoning force in the biotechnology sector, is capturing the spotlight with its focus on pioneering treatments for central nervous system disorders. As a clinical-stage..

Search

Funds

September 25, 2026

Drax targets a bigger role as Britain reshapes its power system

Britain needs more than renewable generation to reshape its power system, and Drax is developing generation, storage and flexibility assets to address that need...

Valeura Energy features in 2026 TSX 30 as energy and commodities drive market interest

Valeura Energy’s inclusion in the 2026 TSX 30 highlights its position within a market increasingly focused on energy security, commodity supply and international production...

Peptide drug development expands beyond GLP-1

GLP-1 success is widening interest in peptide drug development, with the next phase focused on proving clinical value across new therapeutic areas...

Touchstone Exploration moves ahead with Trinidad drilling and production plans

Touchstone Exploration is advancing drilling, well work and production optimisation across Trinidad, with several key operational results expected during the rest of 2026...
Search

Funds

September 25, 2026

FTSE 100

Funds